Optiscan has made key progress in the December quarter with multiple clinical studies advancing to support US FDA submissions ...
A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results